TGFB1 and Hepatic fibrosis: Oxidative stress-induced liver fibrosis was found to be associated with activation of the TGF-β/SMAD pathway, while inhibition of TGF-β signaling is one of the important targets for the treatment of numerous chronic liver diseases [65, 67].